|

Telpegfilgrastim Injection Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Also known as: Peijin, Y-branched pegylated recombinant human granulocyte colony stimulating factor, YPEG-G-CSF

Pipeline

Phase 2: 1

Top Sponsors

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
  • Anhui Provincial Hospital1

Indications

  • Chemotherapy-induced Neutropenia2
  • Cancer2
  • Children1
  • Adolescent1
  • Solid Tumors1

Other2 trials

Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor
Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.